And we have a RECORD here! It is really not usual to see twenty-two cars of the social cab transport Taxik Maxík together, because they serve in all corners of the Czech Republic and are really busy. They offer rides to seniors and the disabled even in locations where public transport doesn't work at all, so it's no wonder that cars are booked whole months in advance. So there MUST BE a really special reason for the meeting – and there WAS! This year we celebrate the jubilee year – a project organized by Charter 77 Foundation, which Dr. Max supports as a general sponsor, was born just ten years ago. There are already 27 cities and towns where cabs of Taxik Maxik help. Their number is still growing, the interest of passengers is not decreasing, and more and more town halls and local charities are interested in operating the service. #wearedrmax #drmaxhelps #drmax
Dr.Max Pharmacy Chain
Nemocnice a zdravotnictví
Praha 1, Prague 14 645 sledující uživatelů
#WeAreDrMax #FirstChoiceWhenItComesToCare
O nás
Who we are Dr. Max is the leading pharmacy chain in Central Europe. Our professional staff manage circa 2,500 patient oriented pharmacies in 6 countries. Each day around 350,000 customers visit one of our modern pharmacies in the Czech Republic, Slovakia, Poland, Romania, Serbia and Italy. In every country where we are active, Dr. Max is dedicated to improving the level of health care available by guaranteeing access to a broad assortment of medicines and pharmacy services at affordable prices. Our pharmacies are an indispensable element of a modern health care system. Our expert and motivated staff support our customers with professional advice and service, helping to improve and protect the health of the population. Our adherence to our core values and our strong customer and patient centricity have allowed us to become the leading pharmacy network in Central Europe. We promise to our loyal customers, our employees and to the public in general that we will continue to uphold the highest standards in the pharmacy industry thus ensuring top quality healthcare for those who place their trust in Dr. Max. Our Core Values Trust – We earn and retain the trust of our customers and patients by offering top quality services, professionalism and fair prices Empathy – we understand that we must listen to the needs of our patients in order to provide the most appropriate support for their health-care and well-being. Customer Care – we not only provide quality medicine but professional services and advice to support the health of our customers Availability – we work to secure convenient locations and work with manufacturers and distributors to ensure secure supply of life saving medicines Affordable Prices – we constantly work to lower the costs of treatment for our customers and patients
- Web
-
http://www.drmax.eu/
Externí odkaz pro organizaci Dr.Max Pharmacy Chain
- Obor
- Nemocnice a zdravotnictví
- Velikost společnosti
- 10 000 a více zaměstnanců
- Ústředí
- Praha 1, Prague
- Typ
- Soukromá společnost
- Datum založení
- 2004
- Speciality
- Pharmacy, Pharmacy Retail, Pharmaceutical Wholesale, Internet Pharmacy a Pharmacy Chain
Lokality
-
Primární
Na Florenci 15
Florentinum (A)
Praha 1, Prague 11000, CZ
Zaměstnanci společnosti Dr.Max Pharmacy Chain
Aktualizace
-
It has been a month since we opened the large-format pharmacy Super Dr. Max in Bratislava🥳. This is a completely new concept, the first of its kind in Slovakia. On 865 m² you can find more than 6.000 products, the Dermo bar with expert personnel providing consultation and diagnostic services, and 2 consultation zones – in the first one we offer to our customers CRP tests or tests of cholesterol levels, risk of diabetes and our modern diagnostic devices can also detect hidden bleeding in the stool or digestive problems. The second consultation zone is dedicated to an in-depth analysis of body composition using the InBody device. Congratulations Dr. Max Slovensko! #SuperDrMax #WeAreDrMax #DrMaxPharma #FirstChoiceWhenItComesToCare #PharmacyNews #HealthcareEurope
-
Dr. Max Pharma soars with 34 % revenue growth in 2023! 🎉 Each working day, six trucks are fully loaded with Dr. Max own label products and shipped to our markets 🚚, with tens of millions being sold in 2023 alone! On top of that, Dr. Max Pharma now wears the crown for the largest pharmaceutical manufacturer, claiming the #1 spot in the Czech Republic 👑. That and so much more boosted our impressive performance in 2023! We’re proud to share that Dr. Max Pharma, the private label manufacturer of Dr. Max Group, announces a phenomenal 34 % revenue growth across all six markets, compared to 2022. We’re grateful for the collaborative efforts of our cross-functional teams within Dr. Max Group 🙏, which contributed to this truly outstanding performance. Dr. Max Pharma remains committed to steady #growth in 2024, driven by our dedication to innovation, quality, and our customers. Here’s to making #healthcare accessible and affordable 🌍👩⚕️! https://lnkd.in/deajzYHw #WeAreDrMax #DrMaxPharma #FirstChoiceWhenItComesToCare #pharmacy #performancereport #HealthcareEurope
Dr. Max Pharma announces impressive revenue growth in 2023 | Dr. Max Holding
drmax.eu
-
Dr. Max Group becomes 2nd largest pharmacy chain in Europe! One milestone reached, more to come! We're excited to share a landmark achievement: Dr. Max has secured the second-largest pharmacy chain position in Europe, fueled by an impressive 20% YoY growth in 2023, reaching €4.6 billion in revenue. This incredible journey wouldn't be possible without our dedicated team of over 20,000 employees across nearly 3,000 pharmacies in 17 European countries. Read the full story to see how we're revolutionizing healthcare and empowering well-being across Europe! #WeAreDrMax #FirstChoiceWhenItComesToCare #HealthcareEurope #pharmacy #leadership https://lnkd.in/dmZe-ysZ
Dr. Max reports 20% revenue growth, continues EU market expansion. | Dr. Max Holding
drmax.eu
-
How would you explicitly showcase the very core of your company? What should be the one word and theme you would pick up? For us, it was and it always will be ▶ CARE ◀. At Dr. Max, care is more than a value; it's a promise. It's the guiding principle behind every decision we make, every product we develop, and every interaction we have. And how does it look in reality? 📣 We’re proud to launch our first pan-European campaign, built upon an unwavering commitment: the Oath of Care. This campaign celebrates Dr. Max as a strong, reliable and major European pharmacy player across different markets, always united by a shared pledge to care for our patients, employees, and partners. One goal, care, connecting the community of 20,000 employees. Easy and simple - join us on this journey as we redefine the meaning of care & wellbeing in Europe! https://lnkd.in/dcaXuWFP #WeAreDrMax #FirstChoiceWhenItComesToCare #OathOfCare #CorporateCampaign #HealthcareEurope #pharmacy P.S.: We're excited to see this campaign come to life country by country - Dr.Max Česko, Dr. Max Romania already on air, Dr. Max Slovensko, Dr.Max Serbia, Dr. Max Italia and Dr.Max Polska to come soon! Creative credits to Ogilvy Romania and Multimedia Est
Dr. Max. First choice when it comes to care
https://www.youtube.com/
-
Dr. Max MAPIT Conference 2024 🎤 : Celebrating 3 days of Collaboration in Prague! Passionate and dedicated colleagues from Dr.Max Česko, Dr. Max Slovensko, Dr. Max Romania, Dr. Max Italia, Dr.Max Polska and Dr.Max Srbija gathered for an inspiring journey at Dr. Max MAPIT conference, where #Product, #IT, and #marketing teams deep-dived into tens of impactful topics💡. Seamlessly blending expertise and creativity, our teams paved the way for groundbreaking projects transcending borders. From engaging discussions to eye-opening workshops, conference fuelled inspiration and solidified our commitment to becoming the absolute leader in Europe. Dr. Max MAPIT wasn't just a conference. It was a glimpse into the future of Dr. Max. Embracing innovation and a customer-centric approach, we're confident in our journey to become Europe's number one, keeping care at the core of everything we do. Thank you to all who contributed to these remarkable three days in Prague and a massive shoutout to the orchestrators of this flawlessly organised event – Miroslav, Jan, and Markéta 👏! #WeAreDrMax #DrMaxMAPITConference #Innovation #Collaboration #FutureForward #FirstChoiceWhenItComesToCare ”
-
-
-
-
-
6
-
-
📈 Exciting financial update from Dr. Max 📢 On Friday, 8th December, Dr. Max successfully closed the books for its first-time ever listed retail bond issue on the Czech capital market with a total volume of CZK 5bn placed. Dr. Max ended up being oversubscribed by ca. CZK 533m, which represents a very solid 110.7% subscription rate. 💬Thomas Bornemann, Group CFO of Dr. Max: “We believe this success reflects the strength of the Dr. Max brand and the trust that customers and investors have placed in us. I would like to express my sincere gratitude to all who made it happen! Their outstanding commitment, flexibility, and professional contributions have been instrumental to achieving this success.” Thank you 🙏 UniCredit (Roman Šťastný, Vilém Antas), Komerční banka (Zubrik Mario, Jiri Krofta), Česká spořitelna, J&T BANKA, Československá Obchodní Banka, A. S., Allen & Overy (Petr Vybíral, Tomáš Kafka, Jan Mourek), White & Case LLP (Petr Hudec), Jan Evan, advokátní kancelář s.r.o. (Jan Evan, Veronika Freibergová), Penta Investments (Marek Hvozdara ), and our Dr. Max team (Lukasz Gorczyca, Zdeněk Havlůj, Ivana Fabryová) We believe that this achievement solidifies our reputation as a first-time issuer among Czech banks and bondholders alike. #DrMax #RetailBond #CzechCapitalMarket #BusinessSuccess #FinancialFlexibility #WeAreDrMax
Prescription for Profits: Dr. Max’s bonds initiative | Dr. Max Holding
drmax.eu
-
🌐 Elevating Success Across Europe - exciting News from Dr. Max Italia 🇮🇹! We're thrilled to announce the strategic acquisition of Neo Apotek S.p.A., propelling our total pharmacies in Italy to over 210. With this move, Dr. Max Group now boasts a remarkable network of almost 3,000 pharmacies across Europe and reinforces its strong position. Leonardo Ferrandino, CEO of Dr. Max Group, states, "This acquisition enhances Dr. Max's established experience and structure, reinforcing our commitment to rapid development in Italy. Dr. Max is already a market leader in numerous European countries, and we are determined to achieve a leadership position in Italy as well." In 2024, Dr. Max continues its commitment to improvement, focusing on people development & wellbeing, efficiency, e-commerce, and delivering innovative solutions. 🌍💊 #DrMax #EuropeanSuccess #PharmacyInnovation #LeadershipGoals #WeAreDrMax #FirstChoiceWhenItComesToCare EN press-release https://lnkd.in/gwwZcmxq
Dr. Max acquisisce Neoapotek S.p.A. raggiungendo il traguardo di oltre 210 farmacie di proprietà in Italia. L'azienda diventa così uno dei principali operatori del settore e consolida la posizione di leadership sul mercato italiano. Leonardo Ferrandino, President & CEO Dr.Max Pharmacy Chain ha dichiarato: “Questa acquisizione strategica ci consente di unire il meglio di entrambe le realtà e di consolidare il nostro impegno verso un percorso di rapido sviluppo anche in Italia: Dr. Max è già un leader di mercato in numerosi Paesi europei e siamo determinati a conquistare una posizione di leadership anche in Italia.” “Questa operazione sancisce un momento storico per l’azienda e per il nostro settore in Italia” afferma Alessandro Urbani, CEO Dr. Max Italia. “Con questa acquisizione abbiamo portato ad oltre 1300 il numero di dipendenti Dr. Max, tra farmacisti e professionisti del settore, dimostrando la concretezza del nostro piano di sviluppo nel Paese e la grande capacità del team Dr. Max di realizzarlo.” Andrea Riva, CEO Neo Apotek, ha aggiunto: “Con Dr. Max condividiamo valori simili e una visione comune di crescita a lungo termine, siamo quindi fiduciosi di fare squadra con uno dei principali attori internazionali del settore, che valorizzerà il talento delle persone di Neo Apotek continuando il percorso di sviluppo intrapreso negli anni scorsi.” L’acquisizione incrementa la capillarità di Dr. Max sul territorio, con un notevole impatto sia nelle località turistiche che nelle città metropolitane, in particolare Milano, Venezia, Verona, Bergamo e Torino. L’operazione si inserisce in un momento di forte sviluppo e crescita degli investimenti per Dr. Max, che ha visto di recente l’apertura del nuovo centro di distribuzione centralizzato a Telgate con una superficie di 14.000 mq, oltre a continui investimenti per potenziare i servizi omnicanale e la piattaforma di e-commerce drmax.it, che attrae già oggi oltre 1 milione di clienti ogni mese. Per approfondimenti https://lnkd.in/eS8B5bJg #WeAreDrMax #DrMax
-